Innova Captab Limited (NSE:INNOVACAP)
856.00
-19.75 (-2.26%)
May 11, 2026, 3:30 PM IST
Innova Captab Revenue
In the fiscal year ending March 31, 2026, Innova Captab had annual revenue of 16.37B INR with 31.66% growth. Innova Captab had revenue of 4.49B in the quarter ending March 31, 2026, with 42.77% growth.
Revenue
16.37B
Revenue Growth
+31.66%
P/S Ratio
3.06
Revenue / Employee
10.23M
Employees
1,600
Market Cap
50.11B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 16.37B | 3.94B | 31.66% |
| Mar 31, 2025 | 12.44B | 1.62B | 15.02% |
| Mar 31, 2024 | 10.81B | 1.55B | 16.72% |
| Mar 31, 2023 | 9.26B | 1.26B | 15.72% |
| Mar 31, 2022 | 8.01B | 3.90B | 94.94% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Strides Pharma Science | 47.26B |
| Akums Drugs and Pharmaceuticals | 42.60B |
| Alivus Life Sciences | 25.12B |
| Indoco Remedies | 18.49B |
| Aarti Pharmalabs | 18.01B |
| Solara Active Pharma Sciences | 12.55B |
| Windlas Biotech | 8.68B |
| Orchid Pharma | 8.11B |